Daniel S. Hsia

ORCID: 0000-0003-2832-3429
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Obesity, Physical Activity, Diet
  • Diabetes Management and Research
  • Diabetes Treatment and Management
  • Diet and metabolism studies
  • Metabolism, Diabetes, and Cancer
  • Physical Activity and Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Diabetes and associated disorders
  • Pancreatic function and diabetes
  • Eating Disorders and Behaviors
  • Gestational Diabetes Research and Management
  • Pharmacology and Obesity Treatment
  • Health and Lifestyle Studies
  • Adipose Tissue and Metabolism
  • Children's Physical and Motor Development
  • Birth, Development, and Health
  • Vitamin D Research Studies
  • Bariatric Surgery and Outcomes
  • Diabetes Management and Education
  • Nutritional Studies and Diet
  • Obesity and Health Practices
  • Long-Term Effects of COVID-19
  • Diet, Metabolism, and Disease
  • Cardiovascular and exercise physiology
  • Breastfeeding Practices and Influences

Pennington Biomedical Research Center
2016-2025

Louisiana State University
2005-2025

University of Minnesota
2024

Emory University
2024

Obesity Society
2024

Baton Rouge Clinic
2018-2024

University of New Mexico
2024

Biomedical Research Institute
2023

Group for the Analysis of Development
2023

Our Lady of the Lake Children's Hospital
2022

Observational studies support an association between a low blood 25-hydroxyvitamin D level and the risk of type 2 diabetes. However, whether vitamin supplementation lowers diabetes is unknown.We randomly assigned adults who met at least two three glycemic criteria for prediabetes (fasting plasma glucose level, 100 to 125 mg per deciliter; hours after 75-g oral load, 140 199 glycated hemoglobin 5.7 6.4%) no diagnostic receive 4000 IU day D3 or placebo, regardless baseline serum level. The...

10.1056/nejmoa1900906 article EN New England Journal of Medicine 2019-06-07
Helena W. Rodbard Julio Rosenstock Luís Henrique Santos Canani Chaicharn Deerochanawong Janusz Gumprecht and 95 more Søren Lindberg Ildiko Lingvay ANETTE L. SØNDERGAARD Marianne Bach Treppendahl Eduard Montanya Pablo Jordão Alcântara Cruz Luis De Loredo Cecilia Luquez Maria Alejandra Moisello Gustavo Akerman Augusto Marise Lazaretti Castro Luís Henrique Santos Canani Branko Akrap Tomislav Bulum Dario Rahelić Ivana Sunic-Grcic Srecko Tusek Iakovos Avramidis Marian Benroubi Triantafyllos Didangelos Gerasimos Karousos Emmanouil Pagkalos Christos Sampanis Maria Somali Zsolt Domboróczki Péter Faludi Zsolt Gaál Piroska Kis-Gombos Győző Kocsis Zoltán Márton Zsolt Sudár Silvio Buscemi Alberto Di Carlo Francesco Dotta Alessandra Gambineri Davide Lauro Marianna Maranghi Małgorzata Arciszewska Janusz Gumprecht Krystyna Matuszewska Ewa Skokowska Teresa Stasinska Svetlana Feofanova Е. О. Филиппова G. R. Galstyan Leyla Gaysina М. А. Куницына Lyudmila Suplotova Slobodan Antić Aleksandar Djukić Milena Mitrović Milica Pešić Edita Stokić Esteban Jódar Encarna Martínez Pedro Mezquita Raya Eduard Montanya Cristóbal Morales Mercè Pérez Vera Margarita Fernández Patricia San José Manel Terns Riera Apussanee Boonyavarakul Chaicharn Deerochanawong Apiradee Sriwijitkamol Dilawar Ajani Eddie Armas Kim Barbel-Johnson Darlene Bartilucci Gholamreza Bonabi Robert S. Busch David Butuk Kevin D. Cannon Craig Chase Louis Chaykin Vasundhara Cheekati Thomas R. A. Davis Belkis Delgado Neil Farris Mark Graves Chi Ha Linda Harper Sharon J. Herring Mitzie Hewitt Daniel S. Hsia Richard A. Jackson Michael Jardula Mark Joyce Mario Juarez Anoop Kapoor Dennis G. Karounos David Kayne Audrey Lacour Gilbert Ledesma Ildiko Lingvay

Efficacy and safety of the glucagon-like peptide 1 (GLP-1) analog oral semaglutide sodium-glucose cotransporter 2 inhibitor empagliflozin were compared in patients with type diabetes uncontrolled on metformin.Patients randomized to once-daily open-label treatment 14 mg (n = 412) or 25 410) a 52-week trial. Key end points change from baseline week 26 HbA1c (primary) body weight (confirmatory secondary). Two estimands addressed efficacy-related questions: policy (regardless trial product...

10.2337/dc19-0883 article EN Diabetes Care 2019-09-17

Eating earlier in the daytime to align with circadian rhythms metabolism enhances weight loss. However, it is unknown whether these benefits are mediated through increased energy expenditure or decreased food intake. Therefore, this study performed first randomized trial determine how meal timing affects 24-hour when intake and frequency matched.

10.1002/oby.22518 article EN Obesity 2019-07-24

The safety, reactogenicity, immunogenicity, and efficacy of the mRNA-1273 coronavirus disease 2019 (Covid-19) vaccine in young children are unknown.Part 1 this ongoing phase 2-3 trial was open label for dose selection; part 2 an observer-blinded, placebo-controlled evaluation selected dose. In 2, we randomly assigned (6 months to 5 years age) a 3:1 ratio receive two 25-μg injections or placebo, administered 28 days apart. primary objectives were evaluate safety reactogenicity determine...

10.1056/nejmoa2209367 article EN New England Journal of Medicine 2022-10-19

Antiobesity medication may be useful for the treatment of pediatric obesity, yet few safe and effective options exist. We evaluated phentermine/topiramate (PHEN/TPM) weight management in adolescents with obesity.This 56-week, randomized, double-blind trial enrolled 12 to less than 17 years age obesity. Participants were randomly assigned 1:1:2 receive either placebo (n=56), mid-dose PHEN/TPM (7.5 mg/46 mg; n=54), or top-dose (15 mg/92 n=113), respectively. All participants received lifestyle...

10.1056/evidoa2200014 article EN NEJM Evidence 2022-04-30
Rachel S. Gross Tanayott Thaweethai Lawrence C. Kleinman Jessica Snowden Erika B. Rosenzweig and 95 more Joshua D. Milner Kelan G. Tantisira Kyung E. Rhee Terry L. Jernigan Patricia A. Kinser Amy L. Salisbury David Warburton Sindhu Mohandas John C. Wood Jane W. Newburger Dongngan T. Truong Valerie J. Flaherman Torri D. Metz Elizabeth W. Karlson Lori B. Chibnik Deepti Pant Aparna Krishnamoorthy Richard Gallagher Michelle F. Lamendola-Essel Denise Hasson Stuart D. Katz H. Shonna Yin Benard P. Dreyer Megan Carmilani Krista Coombs Megan Fitzgerald Nick Güthe Mady Hornig Rebecca Letts Aimee K. Peddie Brittany D. Taylor Andrea S. Foulkes Melissa S. Stockwell Venkataraman Balaraman Amanda Bogie Hülya Bükülmez Allen J. Dozor Daniel Eckrich Amy Elliott Danielle N. Evans Jonathan S. Farkas E. Vincent S. Faustino Laura Vega Sunanda Gaur Ashraf S. Harahsheh Uzma Hasan Daniel S. Hsia Gredia Huerta-Montañez Kathy D. Hummel Matt P. Kadish David C. Kaelber Sankaran Krishnan Jessica S. Kosut Jerry Larrabee Peter Paul Lim Ian C. Michelow Carlos R. Oliveira Hengameh H. Raissy Zaira Rosario-Pabón Judith L. Ross Alice I. Sato Michelle D. Stevenson Maria M. Talavera‐Barber Ronald J. Teufel Kathryn Weakley Emily Zimmerman Marie‐Abèle Bind James Chan Zoe Guan Richard E. Morse Harrison T. Reeder Natascha Akshoomoff Judy L. Aschner Rakesh Bhattacharjee Lesley Cottrell Kelly Cowan Viren D’Sa Alexander G. Fiks Maria Laura Gennaro Katherine Irby Manaswitha Khare Jeremy Landeo Guttierrez Russell J. McCulloh Shalu Narang Manette Ness- Cochinwala Sheila M. Nolan Paul Palumbo Julie Ryu Juan C. Salazar Rangaraj Selvarangan Cheryl R. Stein Alan Werzberger William T. Zempsky Robin L. Aupperle Fiona C. Baker

Most research to understand postacute sequelae of SARS-CoV-2 infection (PASC), or long COVID, has focused on adults, with less known about this complex condition in children. Research is needed characterize pediatric PASC enable studies underlying mechanisms that will guide future treatment.

10.1001/jama.2024.12747 article EN JAMA 2024-08-21

Summary Background Given children's low levels of physical activity and high prevalence obesity, there is an urgent need to identify innovative options. Objective This study aims test the effectiveness exergaming (video gaming that involves activity) reduce adiposity improve cardiometabolic health. Methods randomized controlled trial assigned 46 children with overweight/obesity a 24‐week or control condition. Intervention participants were provided console exergames, gameplay curriculum (1 h...

10.1111/ijpo.12438 article EN Pediatric Obesity 2018-07-20
David M. Nathan William C. Knowler Sharon L. Edelstein Jill P. Crandall Dana Dabelea and 95 more Ronald Goldberg Steven E. Kahn Kieren J. Mather Gilda Trandafirescu Elizabeth A. Walker Marinella Temprosa George A. Bray Kishore M. Gadde Annie Chatellier Jennifer Arceneaux Amber Dragg Crystal Duncan Frank L. Greenway Daniel S. Hsia Erma Levy Monica Lockett Donna H. Ryan David A. Ehrmann Margaret J. Matulik Kirsten Czech Catherine DeSandre Barry J. Goldstein Kevin Furlong Kellie A. Smith Wendi Wildman Constance Pepe Jeanette Calles Juliet Ojito Sumaya Castillo-Florez Anna Giannella Olga Lara Beth Veciana Steven M. Haffner Helen P. Hazuda Maria G. Montez Kathy Hattaway Carlos Lorenzo Arlene Martinez Tatiana Walker Richard F. Hamman Lisa Testaverde Denise Anderson Alexis Bouffard Tonya Jenkins Dione Lenz Leigh Perreault David W. Price Sheila C. Steinke Edward S. Horton Catherine S. Poirier Kati Swift Enrique Caballero Barbara Fargnoli Ashley Guidi Mathew Guido Sharon D. Jackson Lori Lambert Kathleen E. Lawton Sarah Ledbury Jessica Sansoucy Jeanne Spellman Brenda K. Montgomery Wilfred Y. Fujimoto Robert H. Knopp Edward W. Lipkin Ivy Morgan-Taggart Anne Murillo Lonnese Taylor April Thomas Elaine C. Tsai Dace Trence Abbas E. Kitabchi Samuel Dagogo‐Jack Mary E. Murphy Laura J. Taylor Jennifer Dolgoff Debra Clark Uzoma N. Ibebuogu Helen Lambeth Harriet Ricks Lily M.K. Rutledge Judith E. Soberman Mark E. Molitch Boyd E. Metzger Mariana K. Johnson Mimi M. Giles Diane Larsen Samsam C. Pen Mary Larkin Charles McKitrick Heather Turgeon Ellen Anderson Laurie Bissett Kristy Bondi Enrico Cagliero

We examined the effects of metformin on diabetes prevention and subgroups that benefited most over 15 years in Diabetes Prevention Program (DPP) its follow-up, Outcomes Study (DPPOS).During DPP (1996-2001), adults at high risk developing were randomly assigned to masked placebo (n = 1,082) or 850 mg twice daily 1,073). Participants originally continued receive metformin, unmasked, DPPOS (2002-present). Ascertainment development was based fasting 2-h glucose levels after an oral tolerance...

10.2337/dc18-1970 article EN Diabetes Care 2019-03-11

Structured exergaming with prescribed moderate intensity physical activity has reduced adiposity among adolescents. The extent to which adolescents reduce when allowed self-select level is not known.The objective of the study was examine influence on adolescent girls' body composition and cardiovascular risk factors.This randomized controlled trial assigned 41 overweight obese girls aged 14 18 years group-based dance (36 h over 3 months) or a self-directed care control condition. Body size...

10.1111/ijpo.12117 article EN Pediatric Obesity 2016-02-26

Two-thirds of pregnant women exceed gestational weight gain (GWG) recommendations. Because excess GWG is associated with adverse outcomes for mother and child, development scalable cost-effective approaches to deliver intensive lifestyle programs during pregnancy urgent.The aim this study was decrease the proportion who Institute Medicine (IOM) 2009 guidelines.In a parallel-arm randomized controlled trial, 54 (age 18-40 years) were overweight (n=25) or obese (n=29) enrolled test whether an...

10.2196/mhealth.8228 article EN cc-by JMIR mhealth and uhealth 2017-09-13

Given the low levels of physical activity (PA) among adolescent girls in US, there is a need to identify tools motivate increased PA. Although limited evidence that adolescents transfer PA from one context another context, exergames (i.e., video games require gross motor activity) may act as gateway promote overall outside game play. The purpose this study was examine potential effects influences on external behaviors and psychological constructs) 12-week exergaming intervention girls' PA,...

10.1016/j.jshs.2016.11.005 article EN cc-by-nc-nd Journal of sport and health science/Journal of Sport and Health Science 2016-11-23
Leigh Perreault Qing Pan Emily B. Schroeder Rita R. Kalyani George A. Bray and 95 more Samuel Dagogo‐Jack Neil H. White Ronald Goldberg Steven E. Kahn William C. Knowler Nestoras Mathioudakis Dana Dabelea George A. Bray Kishore M. Gadde Annie Chatellier Jennifer Arceneaux Amber Dragg Crystal Duncan Frank L. Greenway Daniel S. Hsia Erma Levy Monica Lockett Donna H. Ryan David A. Ehrmann Margaret J. Matulik Kirsten Czech Catherine DeSandre Barry J. Goldstein Kevin Furlong Kellie A. Smith Wendi Wildman Constance Pepe Ronald Goldberg Jeanette Calles Juliet Ojito Sumaya Castillo-Florez Hermes Flórez Anna Giannella Olga Lara Beth Veciana Steven M. Haffner Helen P. Hazuda Maria G. Montez Kathy Hattaway Carlos Lorenzo Arlene Martinez Tatiana Walker Richard F. Hamman Dana Dabelea Lisa Testaverde Denise Anderson Alexis Bouffard Tonya Jenkins Dione Lenz Leigh Perreault David W. Price Sheila C. Steinke Edward S. Horton Catherine S. Poirier Kati Swift Enrique Caballero Barbara Fargnoli Ashley Guidi Mathew Guido Sharon D. Jackson Lori Lambert Kathleen E. Lawton Sarah Ledbury Jessica Sansoucy Jeanne Spellman Steven E. Kahn Brenda K. Montgomery Wilfred Y. Fujimoto Robert H. Knopp Edward W. Lipkin Ivy Morgan-Taggart Anne Murillo Lonnese Taylor April Thomas Elaine C. Tsai Dace Trence Abbas E. Kitabchi Samuel Dagogo‐Jack Mary E. Murphy Laura Taylor Jennifer Dolgoff Debra Clark Uzoma N. Ibebuogu Helen Lambeth Harriet Ricks Lily M.K. Rutledge Judith E. Soberman Mark E. Molitch Boyd E. Metzger Mariana K. Johnson Mimi M. Giles Diane Larsen Samsam C. Pen David M. Nathan Mary Larkin

OBJECTIVE Regression from prediabetes to normal glucose regulation (NGR) was associated with reduced incidence of diabetes by 56% over 10 years in participants the Diabetes Prevention Program Outcomes Study (DPPOS). In an observational analysis, we examined whether regression NGR also risk for microvascular disease (MVD). RESEARCH DESIGN AND METHODS Generalized estimating equations were used examine prevalence aggregate MVD at DPPOS year 11 people who regressed least once (vs. never) during...

10.2337/dc19-0244 article EN Diabetes Care 2019-07-19

Background: Adverse effects of metformin are primarily related to gastrointestinal (GI) intolerance that could limit titration an efficacious dose or cause discontinuation the medication. Because some side may be attributable shifts in GI microbiome, we tested whether a microbiome modulator (GIMM) used combination with would ameliorate symptoms. Methods: A 2-period crossover study design was 2 treatment sequences, either placebo period 1 followed by GIMM vice versa. Study periods lasted for...

10.1177/1932296815577425 article EN Journal of Diabetes Science and Technology 2015-03-23

OBJECTIVES: To determine the association of antibiotic use with weight outcomes in a large cohort children. METHODS: Health care data were available from 2009 to 2016 for 35 institutions participating National Patient-Centered Clinical Research Network. Participant inclusion required same-day height and measurements at 0 <12, 12 <30, 48 <72 months age. We assessed between any <24 age BMI z score overweight or obesity prevalence (5 years) age, secondary assessments...

10.1542/peds.2018-0290 article EN PEDIATRICS 2018-10-31

Abstract Context Vitamin D regulates glucose homeostasis pathways, but effects of vitamin supplementation on β-cell function remain unclear. Objective To investigate the D3 insulin sensitivity and function. Methods This is a prespecified secondary analysis Type 2 Diabetes study. Overweight/obese adults at high risk for type diabetes (prediabetes) were randomly treated with 4000 IU or matching placebo daily 24 months. Main Outcome Disposition index (DI), as an estimate function, was...

10.1210/clinem/dgab649 article EN The Journal of Clinical Endocrinology & Metabolism 2021-09-02
Coming Soon ...